If you have diabetes, your doctor might suggest Tresiba (insulin degludec) as a treatment option for you. Tresiba is a prescription medication. It’s used long term to manage blood sugar levels in ...

BARCELONA, Spain, Sept. 19, 2019 /PRNewswire/ -- According to new data from the CONCLUDE head-to-head trial, Tresiba ® (insulin degludec) showed an overall lower risk of hypoglycaemia, also known as a ...

Tresiba - a new basal insulin for the treatment of type 1 and type 2 diabetes, developed by Novo Nordisk, a global healthcare company with 90 years of innovation in diabetes care, - has been ...

* Says Tresiba demonstrated lower day-to-day and within-day variability in glucose-lowering effect compared with insulin glargine u300 Sign up here. * Says phase 1 study showed that the day-to-day ...

Tresiba (insulin degludec) may not be safe to use while pregnant or breastfeeding. Factors including the form you take or the condition being treated may determine whether you should use the drug ...

Novo Nordisk (NVO) said new data from a phase 3a trial showed that more people with type 2 diabetes achieved blood sugar target with once-weekly insulin icodec compared with its own once-daily therapy ...

As with other drugs, Tresiba (insulin degludec) can cause side effects, such as headache, upper respiratory infection, and injection site reaction. If side effects of Tresiba become difficult to ...